General Comments / Chat, page-7820

I for one am thinking MD Anderson Petscan donation is to validate EMD incidence and identification process. Then partner and activate IND in the US. Why continue with EUR trial unless Astex sign a partnership, given Dacogen is approved there.

I don’t see a clinical development group with 10 KOL’s being formed for EMD. Perhaps no longer the preferred pathway to approval. Leaves $15m in the kitty to accelerate Cardio quicker once we get reformulation and Governance approval.

Even Sheba AML rates and EMD % is so low we would need 2 years, 30 sites and 600 recruits to hit the 57 patients to validate. I will let you do the math.